Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Ag
21 locations found
- Teva Investigational Site 48
Location: Mobile, Alabama
- Teva Investigational Site 41
Location: Fresno, California
- Teva Investigational Site 71
Location: Huntington Beach, California
- Teva Investigational Site 59
Location: Long Beach, California
- Teva Investigational Site 75
Location: Mission Viejo, California
- Teva Investigational Site 54
Location: San Diego, California
- Teva Investigational Site 29
Location: San Fransisco, California
- Teva Investigational Site 47
Location: Denver, Colorado
- Teva Investigational Site 28
Location: Waterbury, Connecticut
- Teva Investigational Site 53
Location: Clearwater, Florida
- Teva Investigational Site 27
Location: Miami, Florida
- Teva Investigational Site 25
Location: Lawrenceville, Georgia
- Teva Investigational Site 22
Location: Normal, Illinois
- Teva Investigational Site 57
Location: Metairie, Louisiana
- Teva Investigational Site 46
Location: Bangor, Maine
- Teva Investigational Site 40
Location: St. Louis, Missouri
- Teva Investigational Site 42
Location: Sylvania, Ohio
- Teva Investigational Site 67
Location: Fort Mill, South Carolina
- Teva Investigational Site 44
Location: Dallas, Texas
- Teva Investigational Site 69
Location: El Paso, Texas
- Teva Investigational Site 45
Location: San Antonio, Texas
|